Cardiovascular side effects of novel antipsychotics.
Since the introduction of clozapine, several novel antipsychotic agents have been introduced and more are in Phase II/III studies. Because these agents are used clinically as first-line treatment, we need to be more familiar with their side-effect profiles. This manuscript reviews the cardiovascular side effects of currently available novel antipsychotics. The medications reviewed include clozapine, risperidone, olanzapine, quetiapine, and ziprasidone. Guidelines are suggested for the use of these medications in clinical practice.
Department of Psychiatry, Olean General Hospital, Olean, NY, USA. network1@eznet.net
S
S
Gupta
P S
PS
Masand
S
S
Gupta